Quantitative Benefit–Risk Assessment: State of the Practice Within Industry

BACKGROUND: Benefit–risk assessments for medicinal products and devices have advanced significantly over the past decade. The purpose of this study was to characterize the extent to which the life sciences industry is utilizing quantitative benefit–risk assessment (qBRA) methods. METHODS: Semi-struc...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Meredith Y., van Til, Janine, DiSantostefano, Rachael L., Hauber, A. Brett, Marsh, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864811/
https://www.ncbi.nlm.nih.gov/pubmed/33111177
http://dx.doi.org/10.1007/s43441-020-00230-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864811/
https://www.ncbi.nlm.nih.gov/pubmed/33111177
http://dx.doi.org/10.1007/s43441-020-00230-3

Ejemplares similares